Skip to main content

Table 1 Study site and population characteristics

From: Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing

 

Gugulethu TB Clinic (Cape Town, South Africa)

Kanyama TB Clinic (Lusaka, Zambia)

St. Mary’s Day Clinic (Durban, South Africa)

Ifisi Day Clinic (Mbeya, Tanzania)

Overall

No. patients enrolled in parent RCT

419

400

193

83

1095

HIV-infected

133 (32)

268 (67)

114 (59)

49 (59)

564 (52)

HIV uninfected

278 (66)

130 (33)

70 (35)

34 (41)

512 (47)

HIV testing refused

8 (2)

2 (<1)

9 (5)

0 (0)

19 (1)

Demographics of HIV-infected/testing refused patients included in primary analysis (N = 583)

 

N = 141

N = 270

N = 123

N = 49

N = 583

Median age, years (range, IQR)

35 (19-79, 30-40)

35 (19-79, 30-40)

36 (20-63, 29-42)

36 (17-72, 33-48)

36 (17-79, 30-41)

Women (%)a

81 (58)

99 (37)

65 (53)

27 (55)

272 (46)

Previous TBb (%)

69 (49)

42 (16)

37 (30)

2 (4)

150 (26)

Median CD4 cell count, cells/ml (range, IQR)c

261 (6-1089, 137-410)

201 (1-1251, 104-339)

231 (2-1157, 106-494)

91 (1-423, 33-213)

210 (1-1251, 103-375)

HIV-infected on ARTd (%)

51/133 (38)

54/268 (20)

28/114 (25)

2/49 (4)

135/564 (24)

TB outcomes

Sputum TB culture-positive patientse (%)

39 (28)

100 (37)

25 (20)

17 (35)

181 (31)

Clinical TBf (%)

17 (12)

26 (10)

6 (5)

4 (8)

53 (9)

TB-related morbidity at baseline in culture-positive patients

Median TBscore (IQR)g

4 (3-5)

6 (4-7)

5 (4-6)

7 (5-9)

5 (4-7)

  1. Abbreviations: IQR, interquartile range; TB, tuberculosis
  2. Footnotes:aA smaller proportion of patients in Lusaka were female compared to Cape Town, Durban and Mbeya (p-values of <0.0001, 0.003, and 0.015)
  3. bA greater proportion of patients in Cape Town had a history of previous TB compared to Lusaka, Durban, and Mbeya (p-values of <0.0001, 0.002, and <0.0001)
  4. cHIV-infected patients in Mbeya had lower CD4 cell counts compared with Cape Town, Lusaka and Durban (p-value of <0.001 for all comparisons)
  5. dA greater proportion of HIV-infected patients were on ART in Cape Town compared to Lusaka, Durban, and Mbeya (p-value of <0.0001 for all comparisons)
  6. eA lower proportion of patients in Durban were culture-positive for TB compared to Lusaka and Mbeya (p-values <0.001 and 0.05)
  7. fThe median TBscore in patients from Mbeya was higher than Cape Town, Lusaka or Durban (p-values <0.0001 for all comparisons)
  8. gA greater proportion of patients culture-negative patients received TB treatment empirically in Cape Town compared to Durban (p = 0.039)